CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
about
Role of colesevelam in combination lipid-lowering therapyEffect of cholestyramine on bile acid metabolism in normal manTreatment of the arthropathy of familial hypercholesterolaemia.Action of neomycin on the intraluminal phase of lipid absorption.In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patientThe effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.Cholestyramine.Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.Use of cholestyramine in treatment of children with familial hypercholesterolaemia.Disorders of the serum lipoproteins. II. Hyperlipoproteinaemic states.Beyond statins: lipid management to reduce cardiovascular risk.The use of pharmacologic agents in atherosclerosis therapy.Sterol absorption--from lumen to liver.Hypolipidemic drugs and hyperlipoproteinemia.Lipoprotein phenotyping.Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia.New prospects for lipid-lowering drugs.The effect of cholestyramine on intestinal absorption.Absorption of fat-soluble vitamins and sterols.The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
P2860
Q27016027-BFEDCFBF-DA5B-47C9-A8A8-B7EEE27448C6Q28364623-20BCC9C1-6941-4C88-90E3-2DA036BE3465Q33554199-D551CDD4-EA2C-40F9-BE49-C210C6097800Q34056483-6B840032-137A-492D-B92F-F563C7912F05Q34202163-C1B12A59-C76C-460F-810C-A0DD900EE198Q34277430-D392BFD8-E664-4D2B-8095-09215FF7E9C3Q34512082-07A77820-EEC3-42B8-84E8-96FB4F5B2AF7Q34704219-FBF74D08-D2DC-4FE6-8BC5-BE4F32759DF0Q34773656-C0CCA530-5293-4E26-A853-E9E67E2CE5AAQ35150378-D072DAB3-3CD9-4668-9DFA-930BE9944849Q36061945-CE46A7A1-33E2-46C5-A908-964C05CB091BQ38100747-87878A5C-5328-44C0-9CC5-34F528F151FDQ39980044-A1DB2D3E-F515-4F5F-B2A2-3ADB0CFB0EF6Q40001653-A67DAE54-958F-41C9-B7FF-3EED27A8C2CEQ40003087-382DE162-1F66-44F0-A12B-887D2EC21C3AQ40005061-55836D8F-EA9A-40D8-A258-DAC9ED26B1F0Q40134559-A1E6DA62-E4F8-49C0-A8F6-F93F86021EDDQ40408992-4AF87CC9-315B-4834-98F6-470CF9D301F8Q43248827-3DDA3D23-4893-48F9-88CD-FDB685886A1BQ45905357-27DBF3AB-4E7E-40A6-8727-8DC36AADC41CQ53915357-CA79D3BA-89A3-4035-9FCE-A5F24D66105C
P2860
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
description
1965 nî lūn-bûn
@nan
1965 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@ast
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@en
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@nl
type
label
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@ast
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@en
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@nl
prefLabel
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@ast
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@en
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@nl
P1476
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
@en
P2093
S A HASHIM
T B VANITALLIE
P304
P356
10.1001/JAMA.1965.03080170017004
P407
P577
1965-04-01T00:00:00Z